The patients demanding unvaccinated blood transfusions

• by Torie Bosch

• May 27, 2026

Assessment of Clinical Complications and Treatment Approaches in Non-Transfusion-Dependent α- and β-Thalassemia Patients Compared to Matched Controls: A Retrospective Analysis Utilizing Administrative Claims Data in the United States

• by Arielle L. Langer, Amey Rane, Keely S. Gilroy, Jing Zhao, Louise Lombard, Carolyn R. Lew, Sujit Sheth

• March 30, 2026

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Approximately 3% to 4% of the population over the age of 50 is diagnosed with monoclonal gammopathy of undetermined significance (MGUS). It carries a lifelong risk of progression to multiple myeloma and lymphoma, requiring risk-adapted monitoring by multidisciplinary teams.

• by Kimberly Noonan, Kevin Brigle, Charise Gleason, Carrie Bellerive, Mary Steinbach, Deborah Doss

• March 4, 2026

• 17 min

VEXAS Syndrome for the laboratory physician: a case report

• by Chaoying Chen, Miaomiao Chen, Tieqiao Chen, Yong Chen, Lingzhi Liu, Yixi Zhu, Xiaoming Yi, Shuguang He

• May 6, 2026